Alector, Inc. (ALEC) vs Foghorn Therapeutics Inc. (FHTX)

Alector, Inc. and Foghorn Therapeutics Inc. are both Biotechnology companies. Alector, Inc. and Foghorn Therapeutics Inc. are of similar size ($214.4M and $213.8M). Foghorn Therapeutics Inc. grew revenue faster over the last twelve months: 52.0% against −82.9%. Foghorn Therapeutics Inc. has the higher net margin (−175.8% vs −850.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Foghorn Therapeutics Inc. leads on 12 and Alector, Inc. on 3.

Valuation

Metric ALEC FHTX Biotechnology median
P/E n/m n/m 7.88
P/S 15.65 6.73 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 4.49 3.22 10.73
Earnings yield (56.41%) (28.00%) (28.84%)
Free cash flow yield (73.03%) (34.11%) (23.03%)

Profitability

Metric ALEC FHTX Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (912.40%) (198.04%) 0.00%
Net margin (850.13%) (175.78%) 0.00%
Free cash flow margin (1,142.55%) (229.49%) 0.00%
Return on equity (385.11%) 81.90% (57.72%)
Return on assets (42.15%) (30.06%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALEC FHTX Biotechnology median
Revenue growth (TTM) (82.91%) 51.98% 5.64%
EPS growth (last fiscal year) (13.01%) 25.32% —
Revenue growth, 5-year CAGR (0.05%) 135.14% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALEC FHTX Biotechnology median
Debt to equity (0.99) 0.00 0.00
Current ratio 5.26 3.36 4.73
Net debt to EBITDA 1.61 1.88 0.96

Dividend

Metric ALEC FHTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ALEC FHTX Biotechnology median
Market cap 214.38m 213.79m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack